CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Friday reported a loss of $825 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of $2.13 per share.
The results beat Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $2.99 per share.
The biotechnology company posted revenue of $142 million in the period, also topping Street forecasts. Ten analysts surveyed by Zacks expected $127.2 million.
Moderna expects full-year revenue in the range of $1.5 billion to $2.2 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNA at https://www.zacks.com/ap/MRNA
/Netflix%20on%20tv%20with%20remote%20by%20freestocks%20via%20Unsplash.jpg)
/McDonald's%20Corp%20arches%20by-%20TonyBaggett%20via%20iStock.jpg)
/Alphabet%20(Google)%20Image%20by%20Markus%20Mainka%20via%20Shutterstock.jpg)